Y. Yoshizawa

发表

Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model

M. Yamada, Y. Asaoka, H. Noda, 2013, Molecular Pharmacology.

Antipruritic activity of the κ-opioid receptor agonist, TRK-820

J. Kamei, H. Nagase, T. Endoh, 2002 .

Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.

J. Kamei, H. Nagase, T. Endoh, 2002, European journal of pharmacology.

Identification of the mouse calcium‐binding proteins, MRP 8 and MRP 14, in Schistosoma mansoni‐induced granulomas: biochemical and functional characterization

M. Burnett, Sheng‐Chung Lee, W. Epstein, 1997, Journal of leukocyte biology.

Colorimetric determination of citrulline residues in proteins.

W. Epstein, K. Fukuyama, K. Sugawara, 1998, Analytical biochemistry.

Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.

K. Ono, I. Shimada, Hideo Takahashi, 2010, Journal of medicinal chemistry.

Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library*

K. Ono, I. Shimada, Hideo Takahashi, 2009, Journal of Biological Chemistry.

Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives.

Tsubasa Okano, Y. Yoshizawa, Ryoji Hayashi, 2015, Bioorganic & Medicinal Chemistry Letters.

Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation

H. Naitow, N. Kunishima, Y. Matsuura, 2015, FEBS open bio.

Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives.

Tsubasa Okano, Y. Yoshizawa, Ryoji Hayashi, 2015, Bioorganic & medicinal chemistry letters.